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Background. Hypnotic depth but not haemodynamic responsiveness is measured with EEG-
based monitors. In this study we compared heart rate variability (HRV) in unstimulated patients
and stimulation-induced HRV at different levels of anaesthesia.
Methods. A total of 95 ASA I or II patients were randomly assigned to five groups (Group 1:
BIS 45(5), remifentanil 1 ng ml21; Group 2: BIS 45(5), remifentanil 2 ng ml21; Group 3: BIS
45(5), remifentanil 4 ng ml21; Group 4: BIS 30(5), remifentanil 2 ng ml21; Group 5: BIS 60(5),
remifentanil 2 ng ml21). A time- and frequency-domain analysis of the RR interval (RRI) from
the electrocardiogram was performed. HRV before induction, before and after a 5 s tetanic
stimulus of the ulnar nerve, and before and after tracheal intubation was compared between
groups, between stimuli, and between responders to intubation [systolic arterial pressure
(SAP) increase .20 mm Hg, a maximal heart rate (HR) after intubation .90 min21 or both]
and non-responders (ANOVA).
Results. Induction of anaesthesia significantly lowered HR and HRV. Mean RRI before stimu-
lation was higher in G3 than in G1, G2, and G4 (P,0.001), whereas the other HRV parameters
were similar. Intubation induced a greater HRV response than tetanic stimulation. The mean
RRI after intubation was lower in G3 compared with the other groups and the SD of the RRI
after tetanic stimulation was lower in G3 compared with G5. Otherwise, unstimulated HRV
and stimulation-induced HRV were similar in responders and non-responders.
Conclusion. HRV parameters discriminate between awake and general anaesthesia, are differ-
ent after tracheal intubation and a 5 s ulnar nerve stimulation, but do not discriminate
between different levels of haemodynamic responsiveness during surgical anaesthesia.
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Although several types of hypnotic state monitors are now
available,1 2 there is no monitor measuring haemodynamic
responsiveness to noxious stimulation during general
anaesthesia. The EEG-based hypnotic state monitors do
not provide parameters predictive of haemodynamic reac-
tion or movement,3 although the EEG response to noxious
stimulation may reflect the analgesic drug concentration.4
Anaesthetic drug concentrations, although inversely corre-
lated with the probability of a haemodynamic response, do
not allow reliable prediction in every individual subject
because of the variation in anaesthetic drug requirements.
A short electrical stimulation of the ulnar nerve elicits a
short vasoconstriction, which is measurable with pulse
plethysmography5 or laser Doppler,6 and is suppressed by
increasing plasma concentrations of alfentanil5 or sevoflur-
ane.6 This concept of applying a defined sub-maximal
noxious stimulus during general anaesthesia and using the
pulse plethysmography signal as response failed to
†The data were presented in part at the annual meeting of the
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improve the prediction of the haemodynamic response to
tracheal intubation based on hypnotic depth and predicted
effect site remifentanil concentration in a recent random-
ized double-blinded study.7 The same stimulus also elicits
a short increase followed by a short decrease in the heart
rate (HR), as measured with RR intervals (RRI). HR vari-
ability (HRV) is known to discriminate between awake
and sedated or anaesthetized patients.8
The purpose of this study was to compare linear and non-
linear parameters of HRV in patients at different levels of
haemodynamic responsiveness during surgical anaesthesia
before and after two standardized noxious stimuli. We
hypothesized that some HRV parameters would discrimi-
nate between haemodynamic responsiveness at different
levels of surgical anaesthesia, which were defined by differ-
ent BIS levels and different effect-site remifentanil concen-
trations in a previous study.7 HRV data recorded during a
previous study on pulse plethysmography,7 which was
recently published in this journal, were evaluated.
Methods
Patients
Data of the same, 95 ASA I or II patients enrolled in the
pulse plethysmography study7 were evaluated. Patients
with cardiovascular disease (e.g. arterial hypertension or
antihypertensive treatment, cardiac, cerebrovascular, or
peripheral vascular disease), any relevant pulmonary liver,
kidney, or central nervous system disease, diabetes melli-
tus, alcohol or drug abuse, patients with a difficult airway
(i.e. Mallampati class 3 or higher), or patients unable to
give informed consent were excluded.
Study plan
The study plan has been described previously in detail.7
Briefly, the premedicated patients (midazolam 7.5 mg orally
30 min before induction) were monitored with ECG, non-
invasive blood pressure cuff, and pulse oximeter (Datex AS3
monitor, Datex-Ohmeda, Instrumentarium Corporation,
Helsinki, Finland). A venous cannula was inserted in the non-
dominant arm. An A-2000 XP-BIS monitor (BIS software
version 3.3, Aspect Medical Systems, Nattick, CA, USA) was
installed with the sensor placed frontally, according to the
manufacturer’s instructions.
Skin electrodes for electrical stimulation of the ulnar
nerve were placed on the dominant arm 15 and 23 cm
distal to the cubital fold,6 and connected to a Digitimer
DS7 constant current stimulator with a Digitimer DG2
trigger generator (Digitimer LTD, Hertfordshire, UK) and
a timer device (constructed in our laboratory) with the
positive pole attached proximally.
Before induction, the patients were randomly assigned
to five treatment groups differing in target BIS level, and
in remifentanil bolus and infusion rates using a stratified
randomization protocol. In Groups 1–3, a propofol target-
controlled infusion (Diprifusorw, AstraZeneca, Grafenau,
Switzerland) was titrated to achieve a BIS level of 45(5),
whereas in Groups 4 and 5 the target BIS levels were
30(5) and 60(5), respectively. In Groups 1–3, remifentanil
was administered with an initial bolus of 0.2, 0.4, and
0.8 mg kg21 immediately followed by an infusion of 0.04,
0.08, and 0.2 mg kg21 min21, respectively. In Groups 4
and 5, the remifentanil bolus was 0.4 mg kg21 and the
infusion rate was 0.08 mg kg21 min21.
After recording of baseline data for 5 min, the selected
bolus of remifentanil was given by i.v., and the related
remifentanil infusion was started immediately, followed by
a target-controlled infusion of propofol. The target plasma
propofol concentration was adjusted to achieve and main-
tain the selected BIS level. Muscle relaxation was
achieved with vecuronium 0.15 mg kg21 i.v., injected after
loss of consciousness. After the requested effect of vecuro-
nium was verified by train-of-four (suppression of at least
three of four twitches), a 5 s, 60 mA, 50 Hz, and 0.25 ms
square-wave electrical stimulus7 9 was applied to the ulnar
nerve. After arterial pressure and HR had returned to the
pre-stimulation level, an experienced anaesthetist blinded
to the anaesthetic drug doses and the BIS level performed
orotracheal intubation. During the study, arterial pressure
was measured non-invasively (oscillometric method) at
1 min intervals (arterial pressure cuff on the arm opposite
the pulse oximeter probe). The study was terminated 5 min
after tracheal intubation.
Data recording
Arterial pressure, HR, end-tidal CO2, and SpO2 were
recorded on a laptop computer every 10 s. The BIS values
from the A2000 monitor were recorded every 5 s. The
quality of visualization of the vocal cords according to
Wilson and colleagues10 and the duration of intubation
were recorded. Patients with prolonged intubation (.45 s)
were excluded from the study. The infusion rate of remi-
fentanil was also recorded on a laptop computer every
10 s. The target plasma propofol concentration before tra-
cheal intubation was recorded manually. The ECG signal
was digitized at 128 Hz (A/D conversion card, National
Instruments Corporation, Austin, TX, USA) for off-line
analysis.
Time of induction was defined as the start of the propo-
fol infusion, time of stimulations as start of tetanic stimu-
lation, and time of intubation as start of laryngoscopy.
Heart rate (beats min21), systolic and diastolic arterial
pressure (mm Hg), and BIS values were extracted from the
files, and the mean (SD) value was calculated for the 120 s
periods before induction, before stimulation (with stable
anaesthetic drug concentrations), and before laryngoscopy.
The maximal HR, arterial pressure, and BIS in the 300 s
after intubation were determined. An increase in SAP by
.20 mm Hg compared with pre-laryngoscopy, a maximal
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HR after intubation .90 or both were defined as a
response to tracheal intubation.7 11 The effect-site remifen-
tanil concentration at stimulation and intubation was com-
puted from the recorded dosing history using the
pharmacokinetic and pharmacodynamic parameter set of
Minto and colleagues.12
Analysis of HRV
The R-waves of the ECG were detected automatically.
This automatic detection was later verified visually, and
separated arrhythmia, misclassified beats or both were
manually corrected. A beat-to-beat RR interval (RRI)
signal was constructed as a series of time differences
between the successive R-waves.
The recorded signals from the pre-induction (120–60 s
before the start of propofol), the pre-stimulation
(60–0 s before tetanic stimulation), the post-stimulation
(0–60 s after stimulation onset), the pre-intubation (60–
0 s before start of laryngoscopy), and the post-intubation
(0–180 s after intubation) periods were analysed off-line.
Heart rate variability was quantified with time- and
frequency-domain parameters.13 14 The computed time-
domain parameters were mean RRI, RRI standard devi-
ation (RRI SD), and root of mean squared difference
between successive RRI (RMSSD). The frequency-domain
parameters—low-frequency (LF) power (0.04–0.15 Hz),
high-frequency (HF) power (0.15–0.4 Hz), the LF/HF
ratio, spectral entropy of RRI (0.04–0.4 Hz), HF spectral
entropy (0.12–0.4 Hz)—and the amplitude of RRI varia-
bility (RRI amplitude) were computed. The quantitative
Poincare´ analysis was carried out as described by Tulppo
and colleagues.14 In this analysis, RRI is plotted on an
x–y plane (Fig. 1) so that the current RRI (on the y-axis)
is related to the previous RRI (on the x-axis). This analysis
provides a qualitative way of detecting deterministic pat-
terns in complex data. For quantitative analysis of the plot,
the standard deviations of the Poincare´ plot against the
axes y¼x (SD1) and y0¼2xþ 2m (SD2), where m is the
mean RRI during the epoch of interest, and their ratio
(SD1/SD2) were calculated. SD1 mainly describes the fast
beat-to-beat HRV, while SD2 describes slower components
of HRV.14
Statistics
The randomization procedure has been described pre-
viously.7 The HRV values after the events (induction,
stimulation, and intubation) were normalized to the
pre-event values by dividing the post-event values by the
pre-event values. The post-induction window corresponded
to the pre-stimulation window.
A two-way analysis of variance on ranks was performed
to detect the induction effect and the group effect on the
normalized HRV parameters. Repeated measurements of
two-way analysis of variance on ranks with multiple pair-
wise comparisons among groups (Holm–Sidak test) was
performed on the normalized HRV parameters to detect a
stimulus effect (tetanic stimulation of ulnar nerve, tracheal
intubation) and the group effect. P,0.05 was considered
statistically significant. SigmaStat for Windows Version
3.0 (SPSS Inc., Chicago, IL, USA) was used for the stat-
istical analyses.
The different event-induced HRV variables in respon-
ders and non-responders to tracheal intubation were com-
pared with a Mann–Whitney rank test. A logistic
regression analysis was performed to determine the predic-
tive value on the responder status of the following vari-
ables: the BIS value, the predicted effect-site remifentanil
concentration, the predicted plasma propofol concen-
tration, and the HRV parameters related to tetanic stimu-
lation, which were significantly different between
responders and non-responders.
Results
Patients
A total of 95 patients (57 women and 38 men) were
enrolled. The characteristics of the five treatment groups
were similar (Table 1). Two patients of Group 1 were
excluded from data analysis because of serious arrhyth-
mias throughout the study. Various additional subjects
were excluded from the analysis of induction and stimu-
lation (see below).
Anaesthetic drug concentrations, BIS levels, and
response to intubation
The computed effect-site remifentanil concentrations, the
BIS levels before laryngoscopy, the SAP and mean arterial
pressure (MAP), HRs before induction and before laryngo-
scopy, the quality of vocal cord visualization, and duration
of laryngoscopy and intubation are presented in Table 2.
The increase in SAP, MAP, and HR in response to tracheal
intubation and thus the probability of a response to tra-
cheal intubation (SAP increase .20 mm Hg or maximal
Fig 1 Poincare´ plot of the heart rate (HR) response to tetanic stimulation.
RR intervals (RRI) of the pre- and post-stimulation window.
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HR .90 min21) were significantly different among groups
(one-way ANOVA and x2 test P,0.001, respectively).
HRV before and after induction: comparison among
treatment groups
Because of bad data quality in the pre-induction window,
eight additional patients of Groups 2–5 were excluded,
leaving data of 85 patients for analysis (Tables 3 and 4).
All HRV parameters (time domain and frequency domain)
except for the ratio of Poincare´ SD1/SD2 and LF/HF power
were significantly different before and after induction
(stable anaesthetic conditions, Tables 3 and 4). Except for
mean RRI, which was significantly higher in Group 3 than
in Groups 1, 2, and 4, reflecting the lower HR in the sub-
jects with the highest remifentanil concentration, the HRV
parameters after induction were similar among the groups.
Stimulation-induced HRV: stimulation and
group effect
For the analysis of the effect of tetanic simulation, no
further subjects were excluded, so that data of 93 patients
were analysed. For the analysis of the effect of tracheal
intubation, four additional subjects of Group 1 were
excluded because of prolonged intubation (.45 s) and a
further seven subjects were excluded because of insuffi-
cient data quality in the pre-intubation window. The effect
of tracheal intubation on HRV was therefore analysed in
82 subjects (Tables 5 and 6).
Tetanic stimulation induced a smaller HRV response
(RRI SD and Poincare´ SD2) in Group 3 compared with
Group 5, whereas spectral entropy was higher in Group 2
than in all other groups after tetanic stimulation (Tables 5
and 6).
Tracheal intubation induced a stronger HRV response
than the 5 s tetanic stimulation of the ulnar nerve, in all
parameters of HRV except for root mean squared SD of
RRI and Poincare´ SD1 (Tables 5 and 6). There was a sig-
nificant interaction between group effect and stimulation
effect, implying that the group effect was stimulation
dependent. Mean RRI after tracheal intubation was signifi-
cantly higher in Group 3 compared with Groups 1, 2, and
5, indicating that intubation induced less tachycardia in
subjects with the highest remifentanil concentrations.
Table 1 Characteristics of the study population. The data are given as mean (SD) or numbers of patients. Groups were compared with one-way ANOVA and x2 as
appropriate. SAP, systolic arterial pressure; DAP, diastolic arterial pressure; HR, heart rate
Group 1 Group 2 Group 3 Group 4 Group 5 P-values
Age 38.2(8.9) 40.9(10.5) 39.1(10.1) 35.8(9.0) 40.5(11.0) 0.639
Gender (M/F) 8/9 7/12 7/12 8/11 8/11 0.991
Weight (kg) 70.2(13.6) 68.4(11.6) 69.3(13.2) 69.1(14.9) 74.9(17.1) 0.654
BMI 24.1(3.5) 23.9(3.8) 23.8(3.2) 22.9(3.1) 25.4(4.2) 0.335
ASA I/II 14/3 14/5 16/3 14/5 16/3 0.797
SAP ward (mm Hg) 120(9) 118(12) 118(14) 122(12) 120(12) 0.889
DAP ward (mm Hg) 79(8) 74(8) 75(9) 74(8) 76(10) 0.661
HR ward (min21) 72(10) 75(6) 75(8) 74(12) 73(10) 0.904
Table 2 BIS level, predicted effect-site remifentanil concentrations, predicted plasma propofol concentrations, and haemodynamic response to intubation.7
Numbers are mean (SD). BIS, BIS level before tracheal intubation; Remifentanil, predicted effect-site remifentanil concentration (ng ml21); Propofol, predicted
plasma propofol concentration (mg ml21) before laryngoscopy; P response to intubation, probability of haemodynamic response defined as increase of SAP
.20 mm Hg compared with pre-laryngoscopy, a maximal heart rate after intubation or both .90 min21; SAP, systolic arterial pressure; MAP, mean arterial
pressure; HR, heart rate; SAP-, MAP-, and HR-increase, maximum value after intubation—mean value during 120 s before intubation. One-way ANOVA on ranks
with multiple pairwise comparisons (Dunn’s test): 1P, 0.05 compared with all other treatment groups. 2P,0.05 compared with Group 5, 3P,0.05 compared
with Groups 3 and 5, 4P,0.05 compared with Groups 2 and 3, 5P,0.05 compared with Group 3, 6P,0.05 compared with Groups 3 and 4, 7P,0.05 compared
with Groups 2 and 4, 8P,0.05 compared with Group 3
Group 1 Group 2 Group 3 Group 4 Group 5 P-values
Measured BIS 44(5) 41(6) 43(4) 31(6) 57(4)1 ,0.001
Remifentanil effect site (ng ml21) 1.1(0.1)1 2.1(0.3) 4.7(0.7)1 2.0(0.2) 2.1(0.4) ,0.001
Propofol 3.4(0.9)2 3.2(0.9)2 2.9(0.7) 4.0(0.8)3 2.2(0.5) ,0.001
Laryngoscopy (Wilson10 I/II/III) 11/2/0 15/4/0 12/6/1 14/3/0 13/5/1 0.795
Duration of intubation (s) 18.5(11.0) 16.3(4.9) 16.9(4.4) 16.4(4.9) 17.2(3.7) 0.840
SAP before induction (mm Hg) 129(18) 124(12) 116(31) 127(14) 124(12) 0.622
SAP before laryngoscopy (mm Hg) 105(7) 97(7) 96(8) 100(8) 98(14) 0.064
SAP increase (mm Hg) 30(19)4 17(11) 11(11) 11(8) 22(13)5 ,0.001
MAP before induction (mm Hg) 95(10) 91(7) 91(10) 94(11) 93(8) 0.638
MAP before laryngoscopy (mm Hg) 75(7) 72(6) 71(7) 74(8) 74(11) 0.148
MAP increase (mm Hg) 26(12)6 18(9) 11(11) 12(6) 21(13) ,0.001
HR before induction (min21) 79(19) 79(17) 68(21) 78(16) 78(13) 0.234
HR before laryngoscopy (min21) 63(7) 66(10) 57(7)7 65(11) 61(7) 0.023
HR increase (min21) 21(11)8 20(10) 8(8) 9(7) 15(7) ,0.001
P response to intubation 0.77 0.47 0.05 0.18 0.52 0.03
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Table 3 Heart rate variability before and after induction: induction effect and group effect measured with time-domain parameters. Heart rate variability before induction of anaesthesia (Pre) and before tetanic
stimulation of the ulnar nerve (after induction, under stable anaesthetic conditions, Post). Numbers are median (inter-quartile range). Mean RRI, mean RR interval; RRI SD, standard deviation of RRI; RMSSD, root
mean-squared standard deviation of RRI; Poincare´ SD1 and Poincare´ SD2 (see Fig. 2 for details). Two-way ANOVA on ranks with multiple pairwise comparison among groups to detect induction effect and group effect
(Holm–Sidak test). *Group effect: P,0.05 compared with Groups 1, 2, and 4
Induction
effect
Group
effect
Group 1 (n516) Group 2 (n517) Group 3 (n518) Group 4 (n518) Group 5 (n516)
Pre Post Post Post Pre Post Pre Post Pre Post
Mean
RRI
,0.001 0.25 814.1 (740.87,
872.58)
932.48 (877.61,
970.89)
837.95 (706.37,
903.19)
933.32 (813.85,
1012.27)
876.82 (810.34,
928.35)
1031.05 (954.06,
1113.95)*
774.37 (726.19,
858.76)
920.39 (818.79,
1012.2)
858.67 (714.95,
920.67)
981.65 (902.98,
1034.3)
RRI SD ,0.001 0.896 42.93 (24.07,
62.49)
21.69 (16.24,
32.88)
38.96 (30.31,
67.42)
20.37 (17.5,
30.26)
51.2 (26.45,
74.84)
21.08 (18.93,
25.64)
58.36 (37.09,
65.2)
23.26 (15.14,
25.23)
60.04 (32.76,
77.63)
18.74 (15.03,
25.6)
RMSSD ,0.001 0.722 29.86 (16.48,
35.4)
10.64 (7.74,
13.94)
29.08 (17.08,
42.31)
12.35 (6.97,
19.31)
31.95 (21.19,
48.01)
15.23 (10.07,
19.17)
38.2 (20.12,
60.37)
13.49 (8.95,
23.51)
33.15 (16.47,
53.41)
12.86 (9.39,
16.64)
Poincare´
SD1
,0.001 0.724 21.26 (11.73,
25.2)
7.58 (5.52, 9.93) 20.7 (12.14,
30.11)
8.78 (4.96,
13.76)
22.74 (15.09,
34.22)
10.84 (7.15,
13.69)
27.13 (14.28,
42.94)
9.6 (6.36, 16.75) 23.6 (11.72,
38.02)
9.15 (6.69,
11.84)
Poincare´
SD2
,0.001 0.924 55.93 (32.87,
85.42)
29.6 (22.15,
42.09)
50.15 (40.97,
90.8)
27.35 (23.76,
39.67)
64.5 (35.24,
100.7)
26.32 (24.85,
33.55)
73.55 (50.32,
82.77)
26 (20.65, 32.8) 80.18 (43.31,
105.83)
24.81 (20.05,
33.27)
Table 4 HRV before and after induction: induction effect and group effect measured with frequency-domain parameters. Heart rate variability before induction of anaesthesia (Pre) and before tetanic stimulation of the
ulnar nerve (after induction, under stable anaesthetic conditions, Post). Numbers are median (inter-quartile range). LF power, low-frequency power of RRI variability (0.04–015 Hz); HF power, high-frequency power of
RRI variability (0.15–0.4 Hz); LF/HF ratio, ratio of low- to high-frequency power; entropy, spectral entropy of RRI variability (0.04–0.4 Hz); HF entropy, high-frequency spectral entropy (0.12–0.4 Hz). Two-way
ANOVA on ranks with multiple pairwise comparisons among groups to detect induction effect and group effect (Holm–Sidak test)
Induction
effect
Group
effect
Group 1 (n516) Group 2 (n517) Group 3 (n518) Group 4 (n518) Group 5 (n516)
Pre Post Pre Post Pre Post Pre Post Pre Post
LF power ,0.001 0.464 57.54 (10.6,
89.1)
6.16 (2.26,
19.32)
44.69 (16.37,
72.62)
8.62 (3.36,
27.85)
47.32 (8.83,
214.01)
5.17 (3.37,
7.46)
85.09 (32.21,
144.5)
7.31 (3.28,
10.31)
120.57 (35.45,
228.51)
4.75 (3.94,
12.33)
HF power ,0.001 0.641 26.51 (2.38,
40.02)
1.98 (0.84,
3.49)
26.31 (3.08,
54.17)
3.88 (1.18,
7.54)
18.64 (7.72,
47.77)
4.61 (1.78,
9.41)
29.66 (6.65,
120.25)
5.77 (1.5,
7.86)
29.36 (7.73,
121.44)
2.17 (1.68,
3.89)
LF/HF ratio 0.068 0.462 2.91 (1.58,
6.99)
2.77 (0.95,
7.52)
1.97 (0.92,
4.98)
2.7 (1.45, 5.95) 2.0 (0.83,
8.77)
0.98 (0.43,
2.6)
3.55 (1.54,
7.67)
1.99 (1.07,
2.48)
6.64 (1.64,
9.82)
2.71 (1.28,
4.31)
Entropy ,0.001 0.679 0.78 (0.71,
0.87)
0.83 (0.79,
0.88)
0.77 (0.69,
0.85)
0.81 (0.71,
0.87)
0.79 (0.67,
0.89)
0.84 (0.77,
0.87)
0.76 (0.72,
0.81)
0.85 (0.81,
0.88)
0.73 (0.68, 0.8) 0.85 (0.79,
0.87)
HF entropy ,0.001 0.502 0.83 (0.75,
0.86)
0.86 (0.81,
0.9)
0.8 (0.73, 0.84) 0.84 (0.81,
0.88)
0.81 (0.75,
0.9)
0.84 (0.8,
0.89)
0.82 (0.76,
0.88)
0.87 (0.8,
0.92)
0.79 (0.77,
0.84)
0.86 (0.81,
0.88)
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Table 5 Stimulation-induced HRV: stimulus and group effects, group–stimulus interaction in time-domain parameters. Numbers are median (inter-quartile range) of post-stimulation values normalized to
pre-stimulation values (post-stimulation/pre-stimulation). TET, tetanic stimulation of the ulnar nerve (n¼94); INT, tracheal intubation (n¼82). Two-way ANOVA on ranks with stimulus type, group, and group–stimulus
interaction as factors and normalized post-stimulation HRV variables as dependant variables. †P-values of two-way ANOVA on ranks for group effects, stimulus effects, and group–stimulus interaction. One-way ANOVA on
ranks: group effects at each stimulus: *P,0.05 compared with Groups 1, 2, and 5; **P,0.05 compared with Group 5. Significant values are highlighted bold-italic
Group
effect†
Stimulus
effect†
G–S
interaction†
Group 1 (TET, n517)
(INT, n512)
Group 2 (TET, n519)
(INT, n518)
Group 3 (TET, n519)
(INT, n518)
Group 4 (TET, n5 9)
(INT, n516)
Group 5 (TET, n519) (INT,
n518)
TET INT TET INT TET INT TET INT TET INT
Mean RRI 0.133 <0.001 0.038 1.015 (0.996,
1.035)
0.894 (0.854,
0.962)
1.017 (0.995,
1.025)
0.909 (0.832,
0.968)
1.007 (1.001,
1.02)
0.961 (0.946,
1.021)*
1.012 (1.004,
1.023)
0.938 (0.901,
0.997)
1.011 (0.996,
1.021)
0.913 (0.871,
0.947)
RRI SD 0.053 < 0.001 0.042 1.671 (1.266,
2.281)
2.41 (1.647,
3.826)
1.566 (1.187,
2.107)
3.531 (2.148,
4.445)
1.354 (1.088,
1.704)**
2.278 (1.823,
3.589)
1.615 (1.459,
2.025)
1.943 (1.389,
2.593)
2.314 (1.702,
3.087)
2.448 (1.729,
2.873)
RMSSD 0.865 0.132 0.200 1.148 (0.948,
1.623)
1.128 (0.879,
1.428)
1.23 (1.008,
1.376)
1.018 (0.679,
1.665)
1.094 (0.995,
1.266)
1.233 (1.13,
1.729)
1.2 (1.126,
1.584)
0.985 (0.811,
1.163)
1.402 (0.99,
1.952)
1.082 (0.924,
1.854)
Poincare´ SD1 0.876 0.123 0.200 1.148 (0.954,
1.63)
1.122 (0.875,
1.42)
1.23 (1.009,
1.375)
1.019 (0.674,
1.646)
1.091 (0.995,
1.263)
1.225 (1.124,
1.722)
1.197 (1.126,
1.58)
0.994 (0.806,
1.156)
1.39 (0.988,
1.954)
1.082 (0.919,
1.843)
Poincare´ SD2 0.082 < 0.001 0.034 1.776 (1.254,
2.357)
2.53 (1.653,
4.046)
1.629 (1.234,
2.217)
3.669 (2.276,
4.94)
1.373 (1.119,
1.835)**
2.63 (2.007,
3.884)
1.702 (1.521,
2.23)
2.026 (1.537,
2.868)
2.353 (1.903,
3.26)
2.581(1.803,
3.036)
Table 6 Stimulation-induced HRV: stimulus and group effects, group–stimulus interaction in frequency-domain parameters. Numbers are median (inter-quartile range) of post-stimulation values normalized to
pre-stimulation values (post-stimulation/pre-stimulation). TET, tetanic stimulation of the ulnar nerve (n¼94); INT, tracheal intubation (n¼82). Two-way ANOVA on ranks with stimulus type, group, and group–stimulus
interaction as factors and normalized post-stimulation HRV variables as dependant variables. †P-values of two-way ANOVA on ranks for group effects, stimulus effects, and group–stimulus interaction. One-way ANOVA on
ranks: group effects at each stimulus: *P, 0.05 compared with Groups 1, and 3–5. Significant values are highlighted bold-italic
Group
effect†
Stimulus
effect†
G–S
interaction†
Group 1 (TET, n517)
(INT, n512)
Group 2 ((TET, n519)
(INT, n518)
Group 3 (TET n519)
(INT, n518)
Group 4 (TET, n519)
(INT, n516)
Group 5 (TET, n519)
(INT, n518)
TET INT TET INT TET INT TET INT TET INT
LF power 0.695 < 0.001 0.223 1.291 (0.606,
2.373)
19.118 (4.449,
225.848)
0.717 (0.277,
1.256)
23.188 (4.825,
56.846)
1.465 (0.589,
2.36)
12.059 (6.476,
31.412)
1.322 (0.683,
3.402)
7.232 (4.319,
20.284)
1.135 (0.644,
2.372)
11.118 (4.01,
34.3)
HF power 0.118 < 0.001 0.274 1.001 (0.773,
1.518)
10.328 (4.052,
41.056)
0.772 (0.575,
1.082)
3.19 (0.93,
16.923)
0.689 (0.473,
1.498)
7.945 (3.728,
13.789)
1.393 (0.634,
1.935)
5.791 (2.316,
13.873)
1.222 (0.667,
1.908)
9.013 (1.874,
15.953)
LF/HF ratio 0.931 0.030 0.053 1.671 (0.399,
3.437)
2.502 (0.972,
7.426)
0.777 (0.304,
1.632)
3.583 (1.307,
8.267)
1.609 (0.625,
4.725)
1.491 (0.678,
2.964)
1.286 (0.575,
2.341)
1.094 (0.359,
8.643)
1.546 (0.514,
2.248)
1.516 (0.68,
3.251)
Entropy 0.984 0.017 0.025 0.952 (0.885,
1.095)
0.997 (0.868,
1.033)
1.056 (0.978,
1.183)*
0.892 (0.857,
0.933)
0.967 (0.923,
1.016)
0.942 (0.868,
1.004)
0.952 (0.911,
1.008)
0.941 (0.852,
0.994)
0.987 (0.903,
1.018)
0.945 (0.895,
1.019)
HF entropy 0.565 0.002 0.794 1.008 (0.932,
1.098)
0.998 (0.906,
1.023)
0.996 (0.955,
1.076)
0.927 (0.819,
1.005)
1.017 (0.911,
1.064)
0.927 (0.868,
1.011)
0.943 (0.89,
1.06)
0.923 (0.812,
0.969)
0.988 (0.958,
1.017)
0.957 (0.877,
1.026)
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The grand averages of RRI before and after tetanic
stimulation and tracheal intubation in the five treatment
groups are presented in Figures 2 and 3.
HRV: comparison between responders and
non-responders to tracheal intubation
Of the 91 patients with uneventful intubation, 35 were
responders and 56 were non-responders. Of 82 patients
included in the analysis of intubation-induced HRV, 31
were responders and 51 were non-responders. A total of
17 patients showed purely an arterial pressure response, 6
purely a HR response, and 8 a combined response.
HRV before ulnar nerve stimulation and before the start
of laryngoscopy (i.e. unstimulated HRV) were similar in
responders and non-responders to tracheal intubation (data
not shown). The mean (inter-quartile range) normalized
RRI after intubation in responders and non-responders was
0.867 (0.825–0.912) and 0.959 (0.914–1.001), respect-
ively (P,0.001; i.e. responders became more tachycardic
than non-responders). The other parameters of HRV
response were similar (data not shown).
The HRV induced by ulnar nerve stimulation was also
similar in responders and non-responders (data not
shown). In the logistic regression analysis the BIS level,
the predicted effect-site remifentanil concentration and
the predicted plasma propofol concentration but not
HRV variables were kept as independent parameters.
The BIS level and the predicted effect-site remifentanil
concentration, but not the propofol concentration, were
significant predictors of the responder status. The logistic
regression equation to calculate the probability of
response was therefore similar to a previously published
equation.7
Discussion
Induction of general anaesthesia significantly and substan-
tially changed HRV. Different levels of haemodynamic
responsiveness during general anaesthesia expressed by
the post-hoc probability of blood pressure and HR
response were not reflected by any parameter of HRV,
except that patients with high remifentanil concentrations
were more bradycardic. The SD of the RRI after induction,
the Poincare´ SD1 and SD2, and the RMSSD of RRI were
lower and the entropy of RRI was higher after induction,
reflecting a reduced HRV compared with the awake state.
The LF and the HF power significantly decreased, with the
LF/HF power ratio decreasing in Groups 3–5 and increas-
ing in Groups 1 and 2. The stimulation-induced HRV
response was similar among the groups, but dependent on
the stimulus intensity; intubation induced a stronger HR
response (reflected by most of the parameters) than the 5 s
ulnar nerve stimulation. Responders and non-responders to
tracheal intubation had similar HRV parameters except for
a lower post-intubation HR in non-responders. The predic-
tion of the response to tracheal intubation estimated from
the pre-intubation BIS level and effect-site remifentanil
concentration was not improved by adding HRV
parameters.
HRV reflects autonomic nervous system activity and is
affected by anaesthesia. Several linear and non-linear
methods have been used to assess HRV. The most fre-
quently used linear method is the (frequency domain)
Fig 2 The grand average values of RRI before and after tetanic
stimulation of the ulnar nerve are plotted for each group. The RRI are
normalized to the mean RRI before stimulation (measured RRI/mean RRI
before stimulation). The stimulation induced first a short decrease of RRI
(¼increase of heart rate), which was equal in all groups, followed by an
increase (¼decrease of heart rate). The difference in increase among the
groups visible on the plot was not statistically significant.
Fig 3 The grand average values of RRI before and after tracheal
intubation. The stimulation-induced RRI is similar among the five
treatment groups. The RRI are normalized to the mean RRI before
intubation (measured RRI/mean RRI before intubation). Intubation was
followed by a decrease of RRI (¼tachycardia), which was significantly
smaller in Group 3 (P, 0.05).
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power spectral analysis of RRI, defining a LF band
between 0.04 and 0.15 Hz, and a HF band between 0.15
and 0.4 or 0.5 Hz.15 Another linear method calculates RRI
SD and RMSSD of HRV (time-domain parameters).
Non-linear methods such as spectral entropy or Poincare´
analysis, in contrast to linear methods, are better suited for
non-stationary signals as may occur in patients under
noxious stimulation.16
Our results on the induction effect confirm a previous
study using power spectral analysis of HRV. In that study,
total power, LF power (representing sympathetic tone) and
HF power (representing parasympathetic tone), the LF/HF
ratio, and the HR entropy were significantly reduced
in propofol sedated spontaneously breathing patients
(OAA/S 3) compared with awake patients.17
Other studies have reported partially conflicting results
on induction-induced HRV. Induction with propofol (to a
BIS level of 30) reduced HF but not LF power and LF/HF
ratio, induction with sevoflurane reduced LF but not HF
power, whereas entropy was reduced with both induction
methods in patients under assisted spontaneous respir-
ation.8 Thiopenthal or etomidate induction markedly
reduced both LF power and HF power of HRV,18 whereas
induction with midazolam and intermediate to high-dose
fentanyl in cardiac surgery patients only decreased LF
power independent of the dose.19 Conversely, midazolam
sedation in ICU patients dose-dependently reduced HRV
(frequency-domain parameters) correlating with the
Ramsay score.20 The clinical meaning of a change in HRV
at induction of anaesthesia is limited, because the effect of
induction agents is monitored clinically and eventually by
EEG-derived parameters.
Because opioids predominantly reduce LF power,19 21
reflecting an increased parasympathetic tone, and because
opioids are known to reduce HR increase after noxious
stimulation, one might expect that a relative reduction in
the sympathetic tone by opioids would reduce haemo-
dynamic responsiveness to noxious stimulations. Our data
show that HR increase after intubation was significantly
lower in patients with predicted effect-site remifentanil
concentration of 4.7 ng ml21 (Group 3) compared with the
other groups. Nevertheless, the stimulation-induced HRV
response did not discriminate between the treatment
groups or between responders and non-responders to tra-
cheal intubation, except that RRI SD and Poincare´ RRI SD2
responses after tetanic stimulation were lower in Group 3
(highest remifentanil concentration) compared with Group
5 (highest BIS level, intermediate remifentanil concen-
tration). In another study, intraoperative noxious stimu-
lation did not affect power spectral HRV, and HRV did
not correlate with the humoral stress response in adults.22
Conversely, painful stimulation induced a significant
increase in RRI SD, LF power, and LF/HF ratio, and a
decrease in approximate entropy in propofol-anaesthetized
children.23 Tachycardia induced by surgical skin incision
in adults was reflected by a decrease in mean RRI, an
increase in RRI SD, and a decrease in HF power in
patients under sevoflurane anesthesia.16
Not surprisingly, we found a significant difference of
HRV response induced by two stimuli of different inten-
sity. Tracheal intubation, which is one of the strongest
stimuli, elicited a significantly stronger HRV response
than 5 s tetanic stimulation on the ulnar nerve, which is
weaker than surgical skin incision. In a recent study, the
RRI response to a 30 s tetanic stimulus discriminated
between patients with a plasma remifentanil concentration
of 1 ng ml21 24 and those with 3 or 5 ng ml21. In our
study, the RRI response induced by our 5 s tetanic stimu-
lation was detectable, but did not discriminate between
predicted effect-site remifentanil concentrations of 1.1,
2.1, and 4.7 ng ml21 (Fig. 2). The RRI response to tra-
cheal intubation (Fig. 3), however, discriminated between
4.7 ng ml21 and the lower remifentanil concentrations.
This suggests that only strong or even very strong stimuli
allow discrimination between different remifentanil con-
centrations or different states of haemodynamic respon-
siveness during general anaesthesia.
The prediction of the arterial pressure and HR response
to tracheal intubation based on the BIS level and the pre-
dicted remifentanil concentration was therefore not
improved by HRV response induced by the tetanic stimu-
lation. At present, the state of haemodynamic responsive-
ness during general anaesthesia is best assessed by the
predicted plasma or effect-site opioid concentrations and
using a depth of sedation monitor (e.g. BIS).
The definition of the responder status in this study may
be a limitation. The pre-intubation arterial pressure was
lower than the pre-induction arterial pressure (Table 2).
The maximal SAP after intubation therefore was generally
,160 mm Hg, also including blood pressure responders.
Only an SAP .160 mm Hg was associated with an
increased risk of stroke in heart surgery patients.25 In the
same study, only an HR .100 min21 was associated with
an increased incidence of postoperative myocardial infarc-
tion, and an HR .120 min21 was even associated with
increased mortality.25 Only two patients in our study had a
maximal HR .100 min21, and another two had a
maximal SAP .160 mm Hg after intubation (all in
Groups 1 and 2). The HRV parameters of these ‘heavy
responders’ did not differ from the other responders,
however (data not shown). Although our responder defi-
nition potentially limits the clinical relevance of the
response in the current study, we could not change it,
because our current study re-evaluates data from our pre-
vious study, and thus the same definition had to be used.7
We conclude that HRV in the unstimulated patient dis-
criminates between awake and anaesthetized subjects, and
stimulation-induced HRV response is affected by the
stimulus intensity. The different HRV parameters are
similar in a wide range of surgical anaesthesia with con-
trolled ventilation and are therefore of limited value in
assessing haemodynamic responsiveness.
Heart rate variability and haemodynamic responsiveness
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